Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
98.73
(
-1.91%
)
Bitcoin
74,202.93
(
0.35%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Dub Narcotic

Send PM Follow Ignore
Followers 4
Posts 198
Boards Moderated 0
Alias Born 06/06/2007

Dub Narcotic

Re: None

Thursday, 06/05/2008 2:49:52 PM

Thursday, June 05, 2008 2:49:52 PM

Post# of 257253
FTY720 has death in clinical trial.

FTY720 is NVS's oral Tysabri/Copaxone/Avonex-killer that just started its PIII trial. It showed various safety problems in PII, but I believe this is the first death seen. Novartis is continuing the trial.


http://www.reuters.com/article/rbssHealthcareNews/idUSL0586762720080605
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now